Main Hero Image
About Us Icon

PMZ 2010: Postoperative pain

  • PMZ-2010, an analgesic agent, effective in animal models of analgesia.
  • Potential global market size of about $5.9 billion.
  • PMZ-2010 does not have sedative effect, no action on opiate receptors.
  • Risk of respiratory depression is minimal.
  • PMZ-2010 has mild and short lived hypotensive and bradycardia action therefore less risk of severe fall in blood pressure as compared to clonidine or dexmedetomidine.
  • PMZ-2010 does not produce hypothermia as observed with clonidine.
  • Chemistry, manufacturing and controls for PMZ-2010 are complete.
  • Patent applications pending.
  • Clinical stage – Phase I completed.
  • Link to publications